FDA Drug Application (202221) for ESCITALOPRAM OXALATE by HETERO LABS LTD III

Back to FDA Applications sponsored by HETERO LABS LTD III

Application Number202221
Product Number001
FormSOLUTION;ORAL
DosageEQ 5MG BASE/5ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AA Products in conventional dosage forms not presenting bioequivalence problems
Reference Drug
Drug NameESCITALOPRAM OXALATE
Active IngredientESCITALOPRAM OXALATE

Active IngredientCount
List of drugs with Active Ingredient ESCITALOPRAM OXALATE3


Back to FDA Applications sponsored by HETERO LABS LTD III